Olympus Corporation (OCPNF)
OTC Markets OTCPK · USD · Healthcare · Medical Devices
$11.20 (+0.00%) as of
Key statistics
- Market cap
- 11.90B
- P/E (TTM)
- 27.32
- EPS (TTM)
- 0.41
- Dividend yield
- 1.71%
- 52-week range
- 8.00 – 14.00
- Beta
- 0.26
- Revenue (TTM)
- 1.04T
- Profit margin
- 7.49%
- Volume
- 2.00k
About Olympus Corporation
Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology products. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Hachioji, Japan
- Employees
- 28,138
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.